12:00 AM
Mar 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ibudilast regulatory update

MediciNova said FDA granted Fast Track designation for ibudilast to treat methamphetamine dependence. The phosphodiesterase-4 (PDE-4), leukotriene B4 receptor and nitric oxide...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >